Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336063
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-21
First Post:
2006-06-08
Brief Title:
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 |
| Adult Nasal Type Extranodal NKT-Cell Lymphoma |
| Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma |
| Recurrent Nasopharyngeal Undifferentiated Carcinoma |
| Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 |
Keywords: